C12N 2770/24051
Methods of production or purification of viral material
C12N2770/24051 (Methods of production or purification of viral material) appears on 12 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 16
- Assignees
- 16
- Inventors
- 33
- Latest grant
- 28 Apr 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 3 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 2 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 2 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 3 |
| 2019 | 1 | 0 |
| 2020 | 2 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Production methods28 Apr 2020US 10,633,673 B2Glaxo Group Limited
- Method for rapid generation of an attenuated RNA virus14 Apr 2020US 10,619,137 B2Inserm
- Method for rapid generation of an infectious RNA virus10 Sep 2019US 10,407,667 B2Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Combination purified inactivated vaccine for flaviviruses2 Oct 2018US 10,086,061 B2The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
- Production methods20 Oct 2015US 9,163,249 B2Glaxo Group Limited
- Method for rapid generation of an attenuated rna virus27 Aug 2020US 2020/0270584 A1Inserm
- Method for rapid generation of an infectious rna virus26 Jul 2018US 2018/0208907 A1Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Method for rapid generation of an attenuated rna virus19 Jul 2018US 2018/0201908 A1Inserm
- Combination Purified Inactivated Vaccine for Flaviviruses25 Jan 2018US 2018/0021426 A1The United States of America, as represented by the Secretary, on behalf of the Walter Reed Army
- Production methods14 Jan 2016US 2016/0010111 A1Glaxo Group Limited
Most cited
By later US patents
- Combination purified inactivated vaccine for flaviviruses17US 10,086,061 B2The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · 2018
- Avian embryo cell aggregate biomass for producing tick-born encephalitis virus/virus antigen9US 5,391,491 AImmuno Aktiengesellschaft · 1995
- Avian embryo cell aggregate biomass for producing virus/virus antigen and method for producing virus/virus antigen9US 5,550,051 AImmuno Aktiengesellschaft · 1996
- Production of vaccines7US 7,527,961 B2Crucell Holland B. V. · 2009
- Production of vaccines4US 7,521,220 B2Crucell Holland B. V. · 2009